Home
About
FAQ
History (15)
The aftermath of hip fracture: discharge placement, functional status change, and mortality.
Patient and hospital differences underlying racial variation in outcomes after coronary artery bypass graft surgery.
Surgical volume and outcomes of off-pump coronary artery bypass graft surgery: Does it matter?
A multicentre international randomized parallel group double-blind placebo-controlled clinical trial of EMPAgliflozin once daily to assess cardio-renal outcomes in patients with chronic KIDNEY disease
Impaired Eukaryotic Elongation Factor 1A Expression in Alzheimer's Disease.
See All 15 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Impaired Eukaryotic Elongation Factor 1A Expression in Alzheimer's Disease.
Beckelman BC, Zhou X, Keene CD, Ma T. Impaired Eukaryotic Elongation Factor 1A Expression in Alzheimer's Disease. Neurodegener Dis. 2016; 16(1-2):39-43.
View in:
PubMed
subject areas
Aged
Aged, 80 and over
Alzheimer Disease
Blotting, Western
Female
Hippocampus
Humans
Immunohistochemistry
Male
Neurons
Peptide Elongation Factor 1
authors with profiles
Tao Ma PhD